151 related articles for article (PubMed ID: 12466782)
1. Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: Comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients.
Bax JJ; Visser FC; Poldermans D; Van Lingen A; Elhendy A; Boersma E; Sloof GW; Visser CA
J Nucl Cardiol; 2002; 9(6):587-93. PubMed ID: 12466782
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
[TBL] [Abstract][Full Text] [Related]
3. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
Bax JJ; Veening MA; Visser FC; van Lingen A; Heine RJ; Cornel JH; Visser CA
Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
[TBL] [Abstract][Full Text] [Related]
5. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
Bax JJ; Visser FC; Poldermans D; van Lingen A; Elhendy A; Boersma E; Visser CA
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):452-7. PubMed ID: 11914881
[TBL] [Abstract][Full Text] [Related]
6. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
Schinkel AF; Bax JJ; Valkema R; Elhendy A; van Domburg RT; Vourvouri EC; Bountioukos MA; Krenning EP; Roelandt JR; Poldermans D
J Nucl Med; 2003 Jun; 44(6):877-83. PubMed ID: 12791813
[TBL] [Abstract][Full Text] [Related]
7. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
8. Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
Schröder O; Hör G; Hertel A; Baum RP
Nucl Med Commun; 1998 Sep; 19(9):867-74. PubMed ID: 10581593
[TBL] [Abstract][Full Text] [Related]
9. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
Martin WH; Jones RC; Delbeke D; Sandler MP
Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
[TBL] [Abstract][Full Text] [Related]
10. ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox.
Poussier S; Maskali F; Tran N; Person C; Maureira P; Boutley H; Karcher G; Lacolley P; Régnault V; Fay R; Marie PY
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1745-50. PubMed ID: 20393712
[TBL] [Abstract][Full Text] [Related]
11. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
Bax JJ; Visser FC; Raymakers PG; Van Lingen A; Cornel JH; Huitink JM; Elhendy A; Heine RJ; Visser CA
Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
[TBL] [Abstract][Full Text] [Related]
12. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Reinartz P; Buecker A; Krombach GA; Buell U; Kühl HP
J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.
He W; Acampa W; Mainolfi C; Menna F; Sorrentino AR; Petretta M; Cuocolo A
J Nucl Cardiol; 2003; 10(6):599-606. PubMed ID: 14668771
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
16. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
[TBL] [Abstract][Full Text] [Related]
17. FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against.
Cuocolo A
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):832-5. PubMed ID: 15895227
[No Abstract] [Full Text] [Related]
18. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.
Soares J; Rodrigues Filho F; Izaki M; Giorgi MC; Catapirra RM; Abe R; Vinagre CG; Cerri GG; Meneghetti JC
Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855
[TBL] [Abstract][Full Text] [Related]
19. Acipimox does not augment thallium-201 redistribution in the fasting state.
Gunning MG; Clunie G; Yepes-Mora S; Eastick S; Underwood SR; Bomanji J; Ell PJ
J Nucl Cardiol; 1999; 6(6):620-5. PubMed ID: 10608589
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
